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Although much is known about microRNAs’ regulation in gene expression and their contributions in cell fate, to date, globally
lineage-(cell-) speciﬁc identiﬁcation of the binding events between a transcription factor and its targeting microRNA genes is still
waitingforelucidation.Inthispaper,weperformedaChIP-SeqexperimenttoﬁndthetargetingmicroRNAgenesofatranscription
factor, Egr1, in human erythroleukemia cell line K562. We found Egr1 binding sites near the promoters of 124 distinct microRNA
genes, accounting for about 42% of the miRNAs which have high-conﬁdence predicted promoters (294). We also found EGR1
bind to another 63 pre-miRNAs. We chose 12 of the 187 microRNAs with Egr1 binding sites to perform ChIP-PCR assays and the
positive binding signal from ChIP-PCR conﬁrmed the ChIP-Seq results. Our experiments provide the ﬁrst global binding proﬁle
between Egr1 and its targeting microRNA genes in PMA-treated K562 cells, which may facilitate the understanding of pathways
controlling microRNA biology in this speciﬁc cell line.
1.Introduction
MicroRNAs (miRNAs) are a family of ∼22-nucleotide small
noncoding RNAs in eukaryotes and mainly involve in regu-
lation at posttranscriptional level by translational repression
or degradation their target mRNAs [1, 2]. More than 700
human miRNAs have been identiﬁed up till now [3]a n d
they are estimated to control about one-third of human
known genes [4]. miRNAs have been reported to regu-
late hematopoietic lineage diﬀerentiation, angiogenesis, cell
adhesion and so on [1, 5]. K562 is a cell line deriving from
chronic myeloid leukemia, which is a common progenitor of
megakaryocytic and erythroid lineages of the hematopoietic
stem cell diﬀerentiation. It can be induced to diﬀerentiate
into erythrocytes or megakaryocytes (MK) by hemin and
Phorbol-12-myristate 13-acetate (PMA), respectively, [6–9].
Recently, miRNAs have been found to play a key role in
K562 diﬀerentiation. miR-27a, miR-34a, miR-223 were up-
regulated when K562 was induced to MK status while miR-
27a, miR-223, miR-103, miR-130a, miR-210, and miR-18b
were downregulated when K562 was induced to erythroid
diﬀerentiation [10–13]. The changes of miRNAs expression
level gave clues for their functions in hematopoietic lineage
diﬀerentiation but a more detailed regulation pathway is
anticipated to be understood: by which targets miRNAs
realize their functions in hematopoietic diﬀerentiation and
miRNAs are subjected to which factors controlling their
transcription? Garzon et al. conﬁrmed that miR-130 targets
the transcription factor MAFB and participates in MK
diﬀerentiationbyup-regulatingitsexpressionlevelinCD34+
hematopoietic progenitors [14]. Navarro et al. found that
independently of p53, miR-34a directly regulates expression2 Journal of Biomedicine and Biotechnology
of MYB facilitating megakaryocytic diﬀerentiation of K562
cells and of CDK4 and CDK6, to inhibit the G1/S transition
[11]. Lu et al. found that miR-150 regulates megakaryocyte-
erythrocyte progenitors (MEPs) diﬀerentiation and is pref-
erentially expressed in megakaryocytic lineage. Besides, Lu
et al. identiﬁed that transcription factor MYB is also a
critical target of miR-150 in this regulation [15]. A feedback
loop between Runx1 and miR-27a was found by Ben-Ami
et al. that miR-27a plays a regulatory role in megakaryocytic
diﬀerentiation by attenuating Runx1 expression, and during
megakaryopoiesis, Runx1 exerts positive regulation of miR-
27a expression [10]. While the researches, which deepen
our understanding of the underlying mechanism of cellular
diﬀerentiation involving miRNAs, are based on individual
speciﬁc miRNA, currently the interactions between a TF and
its target miRNAs in this cellular process on a large scale have
been sparsely investigated.
Egr1 is an immediate-early response protein which is
rapidly and transiently induced by various stimuli, such
as diﬀerent growth factors, cytokines, mechanical injury,
shear stress [16]. As a transcription factor, many of its
known transcription target genes are protein coding genes.
Among the known transcriptional targets of Egr1, a part
of genes were implicated in the pathogenesis of vascular
disease, including PDGF-A, PDGF-B, FGF-2, SOD1, p53,
CD44 (see commentary [17]). Besides, Egr1 may regulate
cell interaction with the extracellular matrix by coordinated
induction of TGF-β1, FN, and PAI-1 in human glioblas-
toma cells [18]. Moreover, the Egr1 gene is functionally
implicated in cell proliferation and in the regulation of
apoptosis and is considered as a potential target for prostate
cancer therapy [19]. Few studies in the past, on the other
hand, has been focused on the Egr1’s regulation role on
noncoding target genes except a ﬁnding of Egr1’s role in
hsa-miR-106a transcription. Through hsa-miR-106a, Egr1
indirectly regulates the IL-10 expression [20]. Previous stud-
ies showed that PMA-induced activation of Egr1 expression
is involved in megakaryocytic diﬀerentiation of K562 cells
but the regulation pathway has not been investigated. As an
early response factor, Egr1 may regulate both downstream
protein-coding and noncoding genes. ChIP-Seq, a technique
based on next-generation sequencing, is able to capture the
genome-wide snapshot of protein-DNA interactions in vivo
[21]. The interactions between a TF and its target genes can
be identiﬁed by ChIP-Seq and miRNA genes are also the
targets of TFs. Here we identiﬁed the transcription factor
Egr1 binding sites near miRNA promoters and premiRNAs
inPMA-inducedK562cellsusingChIP-Seq.Combiningwith
the Navarro’s miRNA expression proﬁle [11]b e f o r ea n da f t e r
PMA or hemin treatment in K562 cells, we analyzed the
potential role of Egr1 in diﬀerentiation fate of K562 cells
through targeting miRNA genes.
2.MaterialsandMethods
2.1. Cell Culture. K562 cell was cultured in RMPI 1640
medium containing 10% fetal bovine serum (GIBCO) at
37◦Cw i t h5 %C O 2 incubator. K562 cells were treated by
PMA (10ng/ml) for 2 hours.
2.2. Chromatin Immunoprecipitation (ChIP). ChIP experi-
ment was carried out as described previously [22]. Brieﬂy,
PMA treated K562 cells were crosslinked with 1% formalde-
hyde and incubated at room temperature (RT) for 12
minutes, prior to the addition of glycine to 0.125M followed
byincubationatRTfor5minutes.Chromatinweresonicated
and was capture with the beads coated with EGR1 antibody
(588)(fromSantaCruzBiotechnology)ornoIgG.Thebeads
were then precipitated and washed. Bead complexes were
eluted with elution buﬀer. Samples were incubated overnight
at 65◦C for reversing crosslink. Samples were then incubated
with Proteinase K and RNase A for 2 hours at 50◦C.
DNA was puriﬁed by two rounds of phenol-chloroform
extraction and ethanol precipitation and resuspended in
50μldH 2O.
2.3. Sequencing. Brieﬂy, EGR1 ChIP DNA was sheared into
90–150bp and then was repaired by DNA end-repair kit
(Epicentre). SOLiD adaptors were then added and DNA
was subjected to 19 cycles of PCR (2 × enhancer (invitro-
gen) was added to increase the ampliﬁcation for GC-rich
sequences). PCR product of 180–220bp size was incised
from gel and then was subjected to emulsion PCR. Template
positive beads were collected and extended in the presence
of terminal transferase and Bead Linker (SOLiD reagents,
Applied Biosystems). Extended beads were then deposited
and covalently attached onto slides at >20,000 beads per
panel (SOLiD reagent, Applied Biosystems). Template bead
slides were then loaded onto a SOLiD Analyzer, and cycled
ligation sequencing using the SOLiD Sequencing System was
performed.
2.4. Mapping of the SOLiD Sequencing Data. Sequence
reads from ChIP fragments were aligned to human refer-
ence genome using standard SOLiD mapping pipeline tool
(Corona Lite, [23]), allowing up to 3 mismatches out of
35bp. All mapping was performed in the SOLiD color space
corresponding to dinucleotide encoding of the sequenced
DNA.
2.5.PeakDetectionandMotifAnalysis. Theuniquelymapped
reads were retained for subsequent analysis. An integrated
software CisGenome was used to detect peaks which are
enrichedfrombackgroundreads[24].Thealgorithmapplied
the sliding window method to count the reads and the
window size was set 500bp, a tradeoﬀ size which had best
coverage for the known Egr1 targets and was consistent
with length of DNA fragments from ChIP experiments.
The position with highest density in a window should
contain at least nine reads otherwise the regions will
be discarded. We used the strand ﬁltering function to
make sure each strand meet the minimum three reads
requirement.
All the motif analysis, including known motif mapping
and new motif discovery, in this study were completed by
CisGenome.Theknownmotifsequence(degeneratepattern:
5 -G[T]C[A]GG[T]GGGCG[A,T]-3 ) for EGR1 was curated
from literature [17, 25].Journal of Biomedicine and Biotechnology 3
2.6. miRNA Promoters and PremiRNAs Annotation of Egr1
Binding Sites. We directly applied 294 predicted high-
conﬁdence miRNA promoters [26] with minor revisions to
annotate our Egr1 ChIP-Seq dataset. Firstly, the coordinates
of the predicted promoter regions were converted to the
current version of the human genome (hg18) from hg17
using the liftover utility provided by UCSC Genome Browser
[27]. Then, the miRNA gene names were revised based on
miRBase v13 [3] because they are supposed to be criterion
to link the miRNA expression proﬁle in the subsequent
analysis.
For sequence-speciﬁc factors such as Egr1, previous
studies used a more relaxed region of 8kb surrounding
the promoters [26, 28]. As the length of those predicted
promoters varies, here we deﬁne that the enriched regions
which are located within 5kb regions of predicted promoters
and premiRNAs are candidate Egr1 binding sites.
2.7. Gene Ontology Analysis of the Targets of miRNA. The
experimentally supported miRNA targets were downloaded
from TarBase v5.0 [29]. We chose the Batch-Genes tools
providedbyGOEASTtodoGeneOntology(GO)enrichment
analysis [30]. Given a set of genes, Batch-genes can ﬁnd
statistically signiﬁcantly enriched GO terms among them by
using a species-speciﬁc random background. Hypergeomet-
ric test was chose and the P-value was set to .01 (Yekutieli
FDR adjusted) to call an enriched GO term.
2.8. ChIP-PCR Analysis. We randomly selected seven miR-
NAs together with another ﬁve up-regulated miRNAs after
PMA treatment (hsa-miR-135b, hsa-miR-141, hsa-miR-152,
hsa-miR-199b, hsa-let-7g) [11] among Egr1 target miRNAs
toperformChIP-PCRanalysisandtheircorrespondingChIP
DNA fragments resulted from two diﬀerent cell conditions:
before PMA treatment and after PMA treatment of K562
cells. The designed PCR primers are listed in supplemen-
tary Table 1at supplementary material available online at
doi:10.1155/2010/867517.
3. Results
We performed a ChIP-Seq experiment on next-generation
sequencer SOLiD system for the transcription factor Egr1
in PMA-induced K562 cells. Relying on the hypothesis
that chromatin signatures (H3K4me3) can be used to
locate transcription start sites of most genes in genome,
Marson et al. [26] predicted 294 distinct high-conﬁdence
miRNA promoters utilizing the H3K4me3 dataset from
ChIP-chip and ChIP-Seq experiment. We adopted these
promoterstoannotateourEgr1bindingsitesandanticipated
to ﬁnd Egr1-miRNA gene interactions. We also surveyed
the premiRNA with Egr1 binding signal. ChIP-PCR was
conducted to assess the reliability of part of those binding
events. Besides, a recent published miRNAs expression
proﬁle in the similar cell condition facilitated to analyze
the expression changes of those miRNAs which are bound
by Egr1 in PMA-induced MK diﬀerentiation of K562 cells
[11].
3.1. Bioinformatics Evaluation of the Quality of ChIP-Seq
Experiment. By setting the cutoﬀ 9 during the peak detec-
tion, we got 14,636 enriched regions. Although the negative
binominal model adopted by CisGenome is able to estimate
a stringent false discovery date (FDR) and the FDR was less
than 10% when the peak height is equal to and higher than
17 at the window size of 500bp, we chose to combine the
FDR estimation with further experimentally validations to
determine the threshold and the cutoﬀ 9 is supposed to
compromise the coverage and speciﬁcity of the results.
Here we evaluate our ChIP-Seq experiments by
motif analysis. The enriched regions were scanned
by the canonical EGR1 motif (degenerate pattern: 5 -
G[T]C[A]GG[T]GGGCG[A,T]-3  [17, 25]) within diﬀerent
peak height rank. Among the peaks with height ≥17, 60.8%
possessed the canonical EGR1 motifs. We observed that
the percentages of the canonical EGR1 binding motifs
decreased with peak rank. 43.2% of the full list of peaks
can be found canonical EGR1 binding motifs. Besides, the
sequences extracted from 2042 peaks with high quality
(peak height more than 20) were used to do de novo
motif ﬁnding analysis. We found two novel motifs, one
(5 -GCGG[T]GGGC[T]GG-3 ) resembling the known
consensus of EGR1 binding site [31], and one is the other
(5 -GGGGC[T]GGGG-3 ) resembling the consensus of
EGR1 binding sites which has been identiﬁed by Kubosaki
using ChIP-chip [32]. These information are presumed to
give an overview of the technical quality of this ChIP-Seq
experiments in a bioinformatics way.
We next examined the EGR1 binding sites distribution
relative to protein-gene structure. We found the majority of
the EGR1 binding loci (40.7% of the 14,636 sites) are within
the range from 10kb upstream of the transcription start site
(TSS) to 10kb downstream of the transcription end site.
About 12.2% of the peaks are located within 1kb upstream
of the TSS of the known genes, suggesting the transcriptional
relevance of EGR1. A more detailed discussion of protein-
coding gene targets of EGR1 using this ChIP-Seq experiment
can be found in [33]. Due to the unbiased identiﬁcation
of sequencing method, it is unsurprising to ﬁnd that many
EGR1 binding sites are located in exons, introns, and
intergenic regions.
3.2. Identiﬁcation of the Occupancy of miRNA Promoters and
PremiRNAs by Egr1 in K562 Cells. That 37.3% and 50.2% of
the 14,636 enriched regions are located in intron regions and
intergenicregions,respectively,elicitedourcuriositytocheck
if EGR1 is able to bind to noncoding genes like miRNAs, as
5,091 (91%, 5,604 miRNAs’ context is known in miRBase
v13 [3]) miRNAs’ context is intron. With the emergence
of the predicted miRNA promoters, we ﬁrstly deﬁned those
regions, which are located within 5kb regions upstream and
downstream of the predicted promoters, are candidate bind-
ing sites by Egr1. The promoters of 124 diﬀerent miRNAs
were found with ChIP-Seq signals and they accounts for 42%
of those miRNAs with known predicted promoters. hsa-mir-
10a is one of the miRNA genes and its Egr1 binding signal is
visualized in Figure 1. hsa-mir-10a has two Egr1 ChIP-Seq
enriched binding signals (chr17:44008884-44011068, reads4 Journal of Biomedicine and Biotechnology
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Figure 1: Visualization of Egr1 ChIP-Seq peaks enriched around the promoter of miRNA hsa-mir-10a. Two peaks (chr17:44008884-
44011068, reads count:51; chr17:44013523-44015182, reads count:9) around the promoter of hsa-mir-10a can be detected. Raw signal
represents the aligned tags. Total IP, 5  IP and 3  IP are the signal proﬁle built by sliding windows. 5  IP and 3  IP means
immunoprecipitationed DNA signal which are clustered by the forward and reverse aligned tags, respectively. The ﬁgure is drawed by
CisGenome browser [24].
count:51; chr17:44013523-44015182, reads count:9) near its
predicted promoters (chr17:44014310-44014709).
Although most miRNA genes (469) are still lacking high-
conﬁdencepredictedpromoters,togetacomprehensiveview
of the target miRNA genes, we also surveyed the EGR1
binding signal around all precursor miRNAs (miRBase v13
[3]). 125 precursor miRNAs were found EGR1 binding
signal by the same distance standard for the miRNAs with
promoters (also listed in supplementary Table 1). Among the
125 target miRNAs identiﬁed by precursor coordinates and
124 target miRNAs identiﬁed by promoter coordinates, 62
miRNA genes were found present in both lists (see Figure 2),
thus, 187 miRNAs were found EGR1 binding signal in
all. The reason for those 62 miRNA genes which can be
identiﬁed by both coordinates is that the relative distance to
mature miRNAs is one of elements to score the predicted
miRNA promoters. Among the 12 miRNA genes whose
ChIP-Seq EGR1 binding were conﬁrmed by ChIP-PCR (see
Figure 3), 9 (mir-10a, mir-130b, mir-95, mir-23b, mir-17,
mir-152, mir-141, mir-135b, and mir-199b) were among the
62 miRNAs whose EGR1 binding signal can be identiﬁed
by both the promoters and precursors of miRNAs and the
left 3 ones were only found near the predicted promoters of
miRNAs.
A region containing canonical consensus of a transcrip-
tion factor has great potential to be the targets of this factor.
To determine if the extra 63 miRNAs should be accepted as
the targets of Egr1, the peaks associated with miRNAs were
scanned by Egr1 canonical consensus sequence (degener-
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Figure 2: The overlap of miRNA list with EGR1 binding. 125
precursormiRNAswerefoundEGR1bindingsignalinadditionthat
the promoters of 124 diﬀerent miRNAs were found with ChIP-Seq
signals. 62 miRNA genes were found present in both lists.
61.2% of the peaks associated with miRNA genes (220
peaks in all) were found at least one Egr1 canonical motif
(see Table 1), which is signiﬁcantly more than the ratio of
the full set peaks (Fisher’s exact test, P-value = 9.8 × 10
−8).
However, the diﬀerence of the motif frequency between the
peaks associated with the promoters of miRNAs and the
peaks linking to premiRNAs is not signiﬁcant (Fisher’s exact
test, P-value = .1), so we decided to view the extra 63
miRNAs as the putative targets of Egr1. All miRNAs with
Egr1 binding sites enriched from ChIP-Seq signals are listed
in supplementary Table 1. It is noteworthy that a miRNA
gene may have two or more predicted promoters and a
promoter may have more than one Egr1 binding sites.
Among the 14,636 peaks, most are located in intergenic
and intron region as mentioned above, so we asked the
genomic features of those peaks relating to miRNA. 220
unique peaks are associated with the 187 miRNA genes.
Among them, 40.1% of peaks are located in intron regionJournal of Biomedicine and Biotechnology 5
Table 1: Genomic features (especially intergenic region and intron region) and motif properties of the ChIP-Seq enriched regions associated
with miRNA genes.
No. of peaks located in
intergenic region (ratio)
No. of peaks located in
intron region (ratio) total peak no. No. of peaks with
canonical motif (ratio)
All peaks enriched 7340 (50.2%) 5460 (37.3%) 14,636 6318 (43.2%)
Peaks associated with miRNA
genes (187) 95 (43.2%) 90 (40.1%) 220 135 (61.2%)
Peaks associated with the
promoter of miRNA genes (124) 64 (46.0%) 67 (48.2%) 139 94 (67.6%)
Peaks associated with pre
miRNAs (125) 60 (46.9%) 46 (35.9%) 128 74 (57.8%)
(see Table 1), which is a little more than the ratio of the same
genomic peaks (37.3%) among the whole set of peaks




This is because most premiRNA genes are already located
in intron region and the average length of human intron
r e g i o n si s6 , 2 0 6b p .I nt h i sc a s e ,p e a k sa r o u n dt h e−5kb∼
+5kb of the precursor of miRNA genes can easily be outside
of the intron region. In general, no signiﬁcant increase of
the amount of peaks as putative Egr1-miRNA binding are
located in introns (Fisher’s exact test, P-value = .29).
3.3. Gene Ontology Enrichment Analysis of Egr1-Bound
miRNAs’ Targets. In order to elucidate the functions of the
187 Egr1-bound miRNAs, we examined gene ontologies
(GO) using the web-based analysis toolkit GOEAST [30]
for the targets of those miRNAs as miRNAs regulate
cellular activities via pairing to mRNAs. Since our exper-
imental results are nonmicroarray-based high throughput,
we chose the Batch-Genes tools provided by GOEAST
to do GO enrichment analysis. Given a set of genes,
Batch-genes can ﬁnd statistically signiﬁcantly enriched GO
terms among them by using a species-speciﬁc random
background.
Although most mammalian mRNAs are conserved tar-
gets of miRNAs, a signiﬁcant proportion of false positives
are thought to be included in the predicted miRNA targets.
Here, we chose to analyze those experimentally supported
miRNA targets. Among the 187 Egr1-bound miRNAs, 38
miRNAs were found experimentally validated targets (247)
according to TarBase v5.0 [29]. In the GOEAST analysis, the
247 genes were compared to 18,596 genes as background
and the P-value of a GO term less than.01 (Yekutieli FDR
adjusted) was thought to be enriched using hypergeometric
test. We present the ﬁrst 25 enriched biological process terms
in Table 2 and the full enriched molecular function terms in
Table 3. Interestingly, the statistically signiﬁcantly overrepre-
sented GO biological process terms are highly enriched for
hemopoiesis, immune system development, cell diﬀerentia-
tion and so on, which are the cases supposed to be occurring
in this cell condition. Moreover, among enriched GO molec-
ular function terms, the targets of miRNA genes with EGR1
binding signal include binding, protein binding, similar to
the previous GO enrichment ﬁnding of gene targets of
EGR1 using ChIP-chip [32]. Besides, molecular function GO
terms are signiﬁcant for transcription factor transcription,
transcription factor activity, transcription activator binding,
and transcription activator activity. This results is consistent
with the discovery that transcription factors also prevail
among human miRNA targets [34]. It also supports the
notion that EGR1 acts as an early response protein in
cell events and may trigger a series of transcription factor
activity. Three graphical outputs showing the hierarchical
relationships of enriched GO terms (P ≤ .01, Yekutieli FDR
adjusted)ineachGOcategory(canbeseeninsupplementary
Figures 1–3).
3.4. An Evaluation of the Predicted miRNA Promoters Using
ChIP-Seq. All the predicted miRNA promoters were also
scanned by Egr1 canonical consensus sequence (degenerate
pattern: 5 -G[T]C[A]GG[T]GGGCG[A,T]-3  [17, 25]) and
77 predicted promoters (refer to 74 miRNA genes) were
found canonical Egr1 motifs. Among the 77 promoters with
motif, 33 (42.9%, refer to 31 miRNA genes) have real Egr1
binding signals based on our ChIP-Seq experiment and
they are listed in Table 4. According to the data, we found
that hsa-mir-142 has 45 consensus sites dispersed among
its promoters and correspondingly, 10 Egr1 binding regions
identiﬁed by ChIP-Seq were enriched with reads count above
nine. miR-142 is one of ﬁve miRNAs (miR-142, miR-144,
miR-150, miR-155 and miR-223) which are highly speciﬁc
for hematopoietic cells according expression comparison
[35].
3.5. Egr1 Bound-miRNAs’ Expression in PMA-Induced K562
Cells. The set of Egr1 bound-miRNA genes identiﬁed by
ChIP-Seq do not necessarily mean that they are regulated
by the transcription factor Egr1. However, if the expression
level of Egr1 bound-miRNAs ﬂuctuates concomitantly with
the expression changes of Egr1 during MK diﬀerentiation
induced by PMA, it may suggest the function relevance
of their interactions. Recently, Navarro et al. compared
286 miRNAs expression at diﬀerent time point (0 days,
2 days, and 4 days) after PMA treatment of K562 cells
by miRNA microarray [11]. The expression level of most
miRNA genes increased with PMA induction according to
the microarray analysis. Since the K562 cells used in our6 Journal of Biomedicine and Biotechnology
Table 2: Enrichment of Gene Ontology biological process terms in targets of miRNAs with EGR1 ChIP-Seq hits.
GO term IDs Enriched GO terms P-value
GO:0009987 Cellular process 5.06E −08
GO:0048513 Organ development 9.35E −06
GO:0006357 Regulation of transcription from RNA polymerase II promoter 1.09E −05
GO:0060056 Mammary gland involution 1.29E −05
GO:0044237 Cellular metabolic process 3.30E −05
GO:0060443 Mammary gland morphogenesis 3.65E −05
GO:0022612 Gland morphogenesis 6.49E −05
GO:0048731 System development 1.26E −04
GO:0030097 Hemopoiesis 1.32E −04
GO:0002520 Immune system development 1.43E −04
GO:0045944 Positive regulation of transcription from RNA polymerase II promoter 1.45E −04
GO:0030154 Cell diﬀerentiation 1.53E −04
GO:0030155 Regulation of cell adhesion 1.80E −04
GO:0048856 Anatomical structure development 1.85E −04
GO:0042127 Regulation of cell proliferation 2.03E −04
GO:0009888 Tissue development 3.87E −04
GO:0048869 Cellular developmental process 3.87E −04
GO:0048534 Hemopoietic or lymphoid organ development 3.87E −04
GO:0010468 Regulation of gene expression 4.29E −04
GO:0008285 Negative regulation of cell proliferation 5.44E −04
GO:0006928 Cellular component movement 6.05E −04
GO:0007162 Negative regulation of cell adhesion 6.10E −04
GO:0042060 Wound healing 6.14E −04
GO:0014068 Positive regulation of phosphoinositide 3-kinase cascade 8.61E −04
GO:0032502 Developmental process 9.71E −04
Table 3: Enrichment of Gene Ontology molecular function terms in targets of miRNAs with EGR1 ChIP-Seq hits.
GO term IDs Enriched GO terms P-value
GO:0005515 Protein binding 2.93E −05
GO:0030528 Transcription regulator activity 1.89E −04
GO:0051879 Hsp90 protein binding 2.64E −04
GO:0003700 Transcription factor activity 8.36E −04
GO:0004722 Protein serine/threonine phosphatase activity 9.73E −04
GO:0004716 Receptor signaling protein tyrosine kinase activity 1.53E −03
GO:0030618 Transforming growth factor beta receptor, pathway-speciﬁc cytoplasmic mediator activity 1.62E −03
GO:0005488 Binding 2.74E −03
GO:0003702 RNA polymerase II transcription factor activity 3.38E −03
GO:0033613 Transcription activator binding 6.08E −03
GO:0016563 Transcription activator activity 7.22E −03
GO:0005072 Transforming growth factor beta receptor, cytoplasmic mediator activity 8.44E −03
GO:0034713 Type I transforming growth factor beta receptor binding 8.44E −03
ChIP experiment were also treated by PMA and the snapshot
of interactions between Egr1 and its target DNAs were
captured after 1.5h PMA treatment, we directly applied this
expression proﬁle of miRNAs to investigate if the binding
by Egr1 contributes to the regulation of miRNA expression.
According to the microarray analysis of protein-coding genes
(data not shown), we found that the expression of Egr1
in PMA-treated K562 cells increased to 7.5-fold of that in
the untreated cells. We found that among those miRNAs
with Egr1 binding sites, the expression level of 46 mature
miRNAs had increased at least two fold after two days PMA
treatment and 16 of them showed signiﬁcant expression
changes with at least ﬁve fold increase based on Navarro’s
miRNA microarray analysis [11]. These 16 mature miRNAsJournal of Biomedicine and Biotechnology 7
Table 4: The list of miRNA promoters with both Egr1 motif and ChIP-Seq peak. mir TSS start and mir TSS end is the start and stop of the
predicted promoters. score is the cumulative score for each predicted promoter. motif num is the count of the Egr1 motifs in the promoter
regions of miRNAs.
mir name mir TSS start mir TSS end score strand chr reads count peak summit motif num
hsa-mir-200b 1088265 1090140 10 + chr1 11 1091461 2
hsa-mir-200b 1088265 1090140 10 + chr1 10 1094077 2
hsa-mir-200b 1088265 1090140 10 + chr1 9 1086834 2
hsa-mir-30e/30c-1
(cluster-hsa-mir-30a)
40929851 40930051 19 + chr1 25 40930041 1
hsa-mir-92b 153429179 153434335 10 + chr1 13 153430306 3
hsa-mir-92b 153429179 153434335 10 + chr1 11 153428517 3
hsa-mir-146b 104184797 104186757 10 + chr10 23 104185405 2
hsa-mir-132/212
(cluster-hsa-mir-132)
1899412 1901670 10 − chr17 23 1900085 4
hsa-mir-132/212
(cluster-hsa-mir-132)
1899412 1901670 10 − chr17 23 1903969 4
hsa-mir-10a 44014310 44014709 15 − chr17 51 44010351 1
hsa-mir-10a 44014310 44014709 15 − chr17 9 44014535 1
hsa-mir-142 53379405 53785839 10 − chr17 14 53757151 45
hsa-mir-142 53379405 53785839 10 − chr17 14 53516188 45
hsa-mir-142 53379405 53785839 10 − chr17 13 53765628 45
hsa-mir-142 53379405 53785839 10 − chr17 11 53760775 45
hsa-mir-142 53379405 53785839 10 − chr17 11 53383253 45
hsa-mir-142 53379405 53785839 10 − chr17 10 53740717 45
hsa-mir-142 53379405 53785839 10 − chr17 10 53671689 45
hsa-mir-142 53379405 53785839 10 − chr17 9 53739084 45
hsa-mir-142 53379405 53785839 10 − chr17 9 53711312 45
hsa-mir-142 53379405 53785839 10 − chr17 9 53747880 45
hsa-mir-24-2/27a/23a
(cluster-has-mir-23a)
13818427 13819944 1 − chr19 10 13814707 2
hsa-mir-642 50863241 50863441 20 + chr19 18 50863778 1
hsa-mir-99b/let-7e/125a
(cluster-has-mir-99b)
56883717 56886813 10 + chr19 17 56886253 5
hsa-mir-99b/let-7e/125a
(cluster-has-mir-99b)
56883717 56886813 10 + chr19 10 56884005 5
hsa-mir-149 241040800 241041000 9 + chr2 10 241042627 1
hsa-mir-149 241043770 241044582 10 + chr2 10 241042627 1
hsa-mir-124-3 61276703 61277978 9 + chr20 33 61280947 2
hsa-mir-124-3 61276703 61277978 9 + chr20 10 61274186 2
hsa-mir-124-3 61278418 61280978 10 + chr20 33 61280947 3
hsa-mir-124-3 61278418 61280978 10 + chr20 10 61274186 3
hsa-mir-185 18388530 18388730 20 + chr22 38 18388406 1
hsa-mir-185 18388530 18388730 20 + chr22 36 18384025 1
hsa-mir-185 18388530 18388730 20 + chr22 10 18392254 1
hsa-mir-301b/130b
(cluster-hsa-mir-130b)
20335495 20337979 10 + chr22 20 20338454 1
hsa-mir-301b/130b
(cluster-hsa-mir-130b)
20335495 20337979 10 + chr22 19 20341434 1
hsa-mir-301b/130b
(cluster-hsa-mir-130b)
20335495 20337979 10 + chr22 9 20332712 1
hsa-mir-301b/130b
(cluster-hsa-mir-130b)
20335495 20337979 10 + chr22 9 20330784 1
hsa-mir-425/191
(cluster-hsa-mir-191)
49029742 49035883 10 − chr3 11 49033588 38 Journal of Biomedicine and Biotechnology
Table 4: Continued.
mir name mir TSS start mir TSS end score strand chr reads count peak summit motif num
hsa-mir-148a 25955148 25959801 10 − chr7 12 25957595 2
hsa-mir-96/183
(cluster-hsa-mir-96)
129204548 129210298 10 − chr7 23 129207821 7
hsa-mir-96/183
(cluster-hsa-mir-96)
129204548 129210298 10 − chr7 9 129200022 7
hsa-mir-335 129919123 129919323 10 + chr7 13 129919298 2
hsa-mir-596 1752393 1753192 10 + chr8 13 1752487 1
hsa-mir-32 110921946 110922146 19 − chr9 9 110922058 1
hsa-mir-455 115957951 115958151 20 + chr9 14 115956609 1
hsa-mir-219-2 130194040 130195803 10 - chr9 9 130196326 2
were hsa-miR-181a, hsa-miR-181b, hsa-miR-212, hsa-miR-
132, hsa-miR-135b, hsa-miR-141, hsa-miR-152, hsa-miR-
199b,hsa-let-7g,hsa-let-7b,hsa-miR-149,hsa-miR-153,hsa-
miR-346, hsa-miR-375, hsa-miR-200a, and hsa-miR-200b.
miR-181b and miR-181a are members of miR-181 cluster,
which increased 133-fold and 19-fold, respectively. miR-
132 and miR-212, in the miRNA miR-132/miR-212 cluster,
share a promoter, whose region has two Egr1 binding
sites. They were also highly up-regulated with the former
increasing 10-fold and the latter increasing 6-fold. These
data may suggest that due to PMA stimulating, coupling to
Egr1 up-regulation during megakaryocytic diﬀerentiation,
the expression of miRNA genes, which are bound and
activated by the transcription factor Egr1, also increased.
3.6. Analyzing Egr1-miRNA Binding Events by ChIP-PCR.
ChIP-PCR assay is a conventional and reliable measure of
whether a locus is a true binding target of a protein of
interest. To experimentally validate the enriched regions
from ChIP-Seq, we performed ChIP-PCR assays for 12
miRNA genes. As showed in Figure 3, signiﬁcant binding
signals of the transcription factor Egr1 can be observed for
12 miRNA genes within the PMA-induced K562 cells, while
for the input DNA, there is no signal can be observed (see
Figures 3(a) and 3(b)). The results here can partially veriﬁed
the ChIP-Seq experiment, however, it cannot be concluded
that the sensitivity of this ChIP-Seq is as high as 100%. It
can be easily envisioned if more ChIP-Seq found targets were
subjected to ChIP-PCR, false positive rate may arise.
To further check that if the expression or the increase
of expression levels of miRNAs can partially attribute
to the binding of the transcription factor Egr1, we also
performed ChIP-PCR analysis for 12 miRNA genes before
PMA treatment (see Figure 3)a n dm a d eaq u a l i t a t i v e
comparison for their Egr1-miRNA binding levels between
these two cell conditions. Among the 12 miRNAs, 5 miRNA
genes (the right column in Figure 3) showed at least
5-fold expression changes before and after PMA-treatment
according to Navarro’s microarray analysis for microRNA
genes [11]. The ChIP-PCR results for two cell conditions
showed that some Egr1-miRNA binding levels signiﬁcantly
changed after PMA treatment as well as those showed
similar binding signals for diﬀerent cell conditions. Among
the 5 miRNAs whose expression levels signiﬁcantly increased
after PMA-treatment, miR-135b, miR-141, miR-152 showed
no Egr1 binding signals before PMA treatment (see the
right ChIP-PCR results in Figure 3), however, the PMA
induced expression increase of transcription factor Egr1
subsequently turned on the Egr1 binding switch to these
three miRNA genes. As analyzed above, miR-135b, miR-
141, miR-152 were among the 16 mature miRNAs with at
least ﬁve fold expression increase after PMA treatment, so
before PMA induced, they still express at a relatively low
level due to other factors although without the factor Egr1’s
transcription. We suspect that like general housekeeping
genes which have low levels of genic transcription whereby
gene products are constitutively produced at low levels
[36], the low level expression of miRNA genes may also
functionalize as housekeeping miRNAs. Once bound by the
key transcription factors and transcriptionally stimulated,
the explosion of their expression is likely to functionally
correlate with the cell fate. For miRNA genes let-7g and
miR-199b, we can observe an Egr1 ChIP binding signal
enhancement before and after PMA treatment, which may
mainly be caused by up-regulation of Egr1. As let-7g and
miR-199b are also among the 16 mature miRNAs with sig-
niﬁcant fold changes, we can conclude that Egr1 may actively
involve in these miRNA genes transcription after PMA
induction.
For the left seven miRNA genes, based on Navrro’
microarray analysis, miR-10a, miR-95, miR-326, miR-23b,
miR-130b also showed two fold expression increase, despite
not as high as that of the above ﬁve miRNA genes, and the
expression level of miR-25 and miR-17 did not show any
changes. The ChIP-PCR results of six of them within the
nontreatment K562 cells showed positive binding signals.
The similar binding signal before and after PMA treatment
of K562 cell between the transcription factor Egr1 and these,
or may be not limited to, six miRNA genes, suggests that the
great expression increases of Egr1 may not be able to increase
all the Egr1-miRNA bindings and therefore stimulate their
transcriptions. It also suggests that only a part of miRNA
genes, which form a regulatory pattern, contributes to this
PMA-induced diﬀerentiation process. As the gene expression
is such a complicated cellular process, diﬀerent regulatory
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Figure 3:ChIP -PCRr esultsof12miRN A sbefor e( −)andafter(+)PMAtreatment.Allthe12miRNAsshowedpositiveEgr1-bindingsignals
after PMA treatment, which veriﬁed the ChIP-Seq results (+Ab).
4. Discussion
Cellular activities can be considered as a succession of
hierarchically acting regulatory states [37]. Identiﬁcation of
miRNA’s targets is necessarily of great signiﬁcance, but it
is also signiﬁcant to detect what factors determine miRNAs
expression. In this report, we have taken the approach of
ChIP-Seq to identify all the miRNAs with known predicted
promoters which are bound by the transcription factor Egr1.
We found that the promoters of 124 distinct miRNAs have
at least one Egr1 binding site. Besides, EGR1 binding signal
was also found near extra 63 premiRNAs. Combing with
the miRNA expression proﬁle of PMA-induced K562 cells,
we were able to ﬁnd that the binding of the transcription
factor Egr1 may be the reason for expression changes of parts
of miRNAs. We believe that these will be instrumental in
unraveling the mechanism of transcriptional regulation of
miRNA genes.
Lineage speciﬁcation is critical in developmental biology
and evidences showed that miRNAs mediate control of cell
fate in megakaryocy-erythrocyte progenitors [15]. As accu-
mulative evidence showed that miRNAs expression diﬀers
between PMA- and hemin-induced K562 diﬀerentiation,
the possible driven power is under revealing. EGR1 is
a zinc ﬁnger family TF who is known as “immediate-
early response factor” and has been implied in megakary-
ocytic diﬀerentiation of K562 cells. Evidences were also
found that Egr1 activation is correlated with downregula-
tion of erythroid-speciﬁc genes and up-regulation of the
megakaryocyte-spceﬁc gene CD41a [8]. The identiﬁcation
of candidate EGR1-targeted miRNAs through this high-
throughput approach signiﬁcantly broadens the repertoire
of biological eﬀects attributable to the TF. As many of
our annotated miRNAs are known to play crucial rules
in hematopoietic diﬀerentiation (miR-27a, miR-10a, etc.),
the role of Egr1 in hematopoietic diﬀerentiation is also
implicated here.
During K562 cell erythroid/MK diﬀerentiation, there
are miRNAs expression signatures speciﬁc to each cell
lineage. For example, a subset of 12 highly up-regulated
miRNAs (miR-34a, miR-181b, miR-299-5p, miR-134, miR-
375, miR-181a, miR-139, miR-222∗, miR-409-3p, miR-221,
miR-212, miR-132) from Navarro’s miRNA microarray in
TPA-treated K562 cells was found to be speciﬁc to MK
diﬀerentiations,whilenoneofthemwasup-regulatedduring
hemin-induced erythroid diﬀerentiation by Northern blot
assay [11]. miR-223 was also up-regulated during PMA-
induced megakaryocytic diﬀerentiation but downregulated
during hemin-induced erythroid diﬀerentiation [12]. Induc-
tion of megakaryocytic diﬀerentiation in K562 cells by PMA
markedly increased miR-27a expression; however, down-
regulation of miR-27a expression occurs upon induction
of K562 cells toward erythroid diﬀerentiation. Runx1 was
the transcription factor which plays a role in the ery-
throid/megakaryocyticlineagedeterminationthroughmedi-
ating regulation of miR-27a [10]. PMA-induced activation
of Egr1 expression has been proved to involve in megakary-
ocytic diﬀerentiation of K562 cells but the regulation
pathway has not been investigated. We therefore investigate
several Egr1-bound miRNAs which behave diﬀerently in
erythroid/megakaryocytic cell lineage to see if Egr1 plays
a role in erythroid/megakaryocytic lineage determination
of K562 cells. The promoters of miRNA cluster hsa-mir-
181a(hsa-mir-181a/181b)andclusterhsa-mir-132(hsa-mir-
132/212) cluster were found Egr1 binding sites according to
our ChIP-Seq experiment. These two miRNA clusters are
possible candidates through which Egr1 acts as a lineage
determinator. Our ChIP-Seq data also showed that near
the two predicted promoters of miR-27a, each had an




























Figure 4: Schematic diagram of miRNA related Egr1’s contribution to erythroid/megakaryocytic lineage determination of K562 cells. mir-
27a,mir-10a,mir-103-1andmir-103-2werefoundEgr1bindingsignalsinthisstudy.Basedonliteraturedata,whenK562cells wereinduced
by PMA, the expression levels of these miRNAs increased. On the contrary, their expression level were found decreased when K562 cells were
induced to erythroid diﬀerentiation.
reads, respectively. DNA sequence of the second ChIP-Seq
enriched regions was found canonical Egr1 motif (degen-
erate pattern: 5 -G[T]C[A]GG[T]GGGCG[A,T]-3 )a n dw e
found three sites with motif, TAGGGGGCG, TCGTGGGCG,
and TCGGGGGCA. So, we suspect that except that Runx1
exerts transcriptional stimulation on miR-27a expression,
the binding of Egr1 may also regulate miR-27a expression
level and therefore contribute to lineage determination of
K562 cells.
Yang et al. characterized and validated that miRNAs
of miR-103 and miR-10a exhibited downregulation after
hemin induction [13], while Navarro’s miRNA microarray
analysis showed that miR-103 and miR-10a increased two
fold after PMA induction [11]. These diﬀerences imply
that like miR-27a, the two miRNAs may also participate
in lineage determination of K562 cells. Meanwhile, our
Egr1 ChIP-Seq results supported that Egr1 binds to the
transcription initiation regions of hsa-mir-103-1 (reads
count:14, canonical motif: TAGGGGGCG), hsa-mir-103-
2 (reads count:25), hsa-mir-10a (two binding sites, reads
count:51; canonical motifs: GCGGGGGCA, GCGTGGGCG,
TCGGGGGCA, GCGTGGGCA; reads count:9; canonical
motifs, GAGGGGGCG), so Egr1 would be the candidate
transcription factor which regulates the expression changes
of miR-103 and miR-10a. Our ChIP-PCR assay conﬁrmed
the Egr1-mir-10a binding. All these data provides key clues
for establishment of regulation network of K562 cell diﬀer-
entiation. The relationship between Egr1 and its targeting
miRNAs discussed above is summarized in Figure 4.
5. Conclusion
By ChIP-Seq, we provide a global binding proﬁle between
the transcription factor Egr1 and its targeting miRNA genes
in PMA-treated K562 cells and found that EGR1 binds to
promoters of 124 miRNAs and precusors of 125 miRNAs.
Among the miRNAs which are bound by Egr1, miR-10a,
miR-25, miR-23b, miR-135b, miR-130b, miR-326, miR-
141, miR-152, miR-199b, miR-95, and let-7g are validated
according to ChIP-PCR.
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